genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Authors
Posts by Kevin Davies
Kevin Davies
37 POSTS
0 COMMENTS
Kevin Davies, PhD, is Editorial Director of GEN and EVP/Executive Editor of The CRISPR Journal and GEN Biotechnology.
Genome Editing
New Report Charts a Course for Heritable Human Genome Editing
Insights
Rosalind Franklin the Scientist
Genome Editing
From the Cultural Revolution to the Gene Therapy Revolution
A-Lists
Blinking Red: 25 Missed Pandemic Warning Signs
Genome Editing
Base Editing Promise in Treating a Mouse Model of Progeria
Genome Editing
Guilty as Charged
Genome Editing
From CRISPR Multiplexing to Pleistocene Park
Genome Editing
NIH Director Backs Moratorium for Heritable Genome Editing
GEN Edge
On Higher Ground: The Dilemma on Gene Therapy Pricing
Genome Editing
Promising Results Reported in Tay-Sachs Gene Therapy Trial
1
2
3
4
Page 2 of 4
Scroll Up